Healthcare / Medical Instruments & SuppliesUpdated 2026-05-10 22:07 UTC

LON/0I3I stock hub

LON/0I3I has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

LON/0I3Iis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

8.6B

London Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

LON/0I3I

In the news

Latest news · LON/0I3I

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E12.7

P25 12.9P50 16.9P75 23.5

Trailing P/E29.4

P25 15.9P50 22.9P75 35.8

ROE4.9

P25 -54.2P50 2.1P75 13.7

ROIC4.3

P25 -38.1P50 3.3P75 11.9

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All LON/0I3I market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

228

Groups with data

Currency

USD

Showing 228 of 228 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	United States
Country code	UK
Employees	15,000
Employees Change	-1,000%
Employees Change Percent	-6.25
Enterprise value	$10.5B
Exchange	London Stock Exchange
Financial currency	USD
First seen	2026-05-10
Industry	Medical Instruments & Supplies
Isin	US2166485019
Last refreshed	2026-05-10
Market cap	$8.6B
Price	$59.78
Price currency	USD
Rev Per Employee	201,752.57x
Sector	Healthcare
Sic	3851
Symbol	lon/0I3I
Website	https://www.coopercos.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	3.41%
EV Earnings	36.02x
EV/EBIT	20.01x
EV/EBITDA	12.43x
EV/FCF	29.43x
EV/Sales	3.46x
FCF yield	4.17%
Forward P/E	12.74x
P/B ratio	1.41x
P/E ratio	29.36x
P/S ratio	2.84x
PE Ratio10 Y	42.55x
PE Ratio3 Y	50.49x
PE Ratio5 Y	39.34x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	17.28%
EBITDA Margin	26.48%
FCF margin	11.83%
Gross margin	65.44%
Gross Profit	$2B
Gross Profit Growth	3.23%
Gross Profit Growth Q	5.3%
Gross Profit Growth3 Y	7.19%
Gross Profit Growth5 Y	10.5%
Net Income	$292.6M
Net Income Growth	-3.37%
Net Income Growth Q	25.41%
Net Income Growth Quarters	1%
Net Income Growth Years	0%
Net Income Growth3 Y	2.28%
Net Income Growth5 Y	-29.15%
Pretax Margin	14.58%
Profit Margin	9.67%
Profit Per Employee	$19,506
Profitable Years	14
ROA	3.64
Roa5y	3.46
ROCE	6.63
ROE	4.87
Roe5y	14.75
ROIC	4.34
Roic5y	4.93

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	-25.79%
Cagr3y	-14.53%
Cagr5y	-10.11%
Div CAGR3	0.74%
Div CAGR5	-15.3%
EPS Growth	-3.02
EPS Growth Q	26.92
EPS Growth Quarters	1
EPS Growth Years	0
EPS Growth3 Y	1.98
EPS Growth5 Y	-29.28
FCF Growth	27.68%
FCF Growth Q	56.82%
FCF Growth3 Y	4.94%
FCF Growth5 Y	18.83%
OCF Growth	11.48%
OCF Growth Q	36.88%
OCF Growth10 Y	8.02%
OCF Growth3 Y	7.73%
OCF Growth5 Y	11.42%
Revenue Growth	5.68x
Revenue Growth Q	6.16x
Revenue Growth Quarters	21x
Revenue Growth Years	5x
Revenue Growth3 Y	7.1x
Revenue Growth5 Y	10.99x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	$0.34
Assets	$9.1B
Cash	$91M
Current Assets	$1.6B
Current Liabilities	$1.2B
Debt	$2B
Debt EBITDA	$2.4
Debt Equity	$0.33
Debt FCF	$5.65
Equity	$6.1B
Interest Coverage	7.44
Liabilities	$3B
Long Term Assets	$7.5B
Long Term Liabilities	$1.8B
Net Cash	$-1.9B
Net Cash By Market Cap	$-22.5
Net Debt EBITDA	$2.41
Net Debt Equity	$0.32
Net Debt FCF	$5.4
Tangible Book Value	$2.1B
Tangible Book Value Per Share	$10.9
WACC	8.66

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	1.34
Inventory Turnover	1.67
Net Working Capital	$753.6M
Quick ratio	0.58
Working Capital	$392.2M
Working Capital Turnover	$3.97

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	0.92%
Dividend per share	$0
Last Dividend	$0.01

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	-25.78%
200-day SMA	73.82
3Y total return	-37.57%
50-day SMA	70.39
50-day SMA vs 200-day SMA	50under200
5Y total return	-41.3%
All Time High	113.7
All Time High Change	-47.41%
All Time High Date	2021-09-09
All Time Low	54.5
All Time Low Change	9.7%
All Time Low Date	2018-04-09
ATR	2.45
Beta	0.89
Ch YTD	-27.32
High	62
High52	89.11
High52 Date	2025-12-05
High52ch	-32.91%
Low	59.78
Low52	59.34
Low52 Date	2026-04-28
Low52ch	0.74%
Ma50ch	-15.07%
Price vs 200-day SMA	-19.01%
RSI	25.44
RSI Monthly	36.06
RSI Weekly	28.46
Sharpe ratio	-0.81x
Sortino ratio	-0.9
Total Return	0.92%
Tr YTD	-27.32
Tr1m	-13.48%
Tr1w	-4.31%
Tr3m	-26.8%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	$523M
Operating Income Growth	-2.62
Operating Income Growth Q	16.92
Operating Income Growth3 Y	8.78
Operating Income Growth5 Y	11.16
Operating margin	17.28

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	193,679,208%
Net Borrowing	-31,907,859
Shares Insiders	0.6%
Shares Institutions	106.12%
Shares Qo Q	-0.71%
Shares Yo Y	-0.92%
Short Ratio	2.61

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$306.7M
Average Volume	759.05x
Bv Per Share	31.25
CAPEX	$-273.5M
Ch1m	-13.48
Ch1w	-4.31
Ch1y	-25.78
Ch3m	-26.8
Ch3y	-37.58
Ch5y	-41.33
Ch6m	-13.79
Change	-1.84%
Change From Open	-2.27
Close	60.9
Days Gap	0.44
Depreciation Amortization	280,128,996.6
Dollar Volume	64,921.1
Earnings Date	2026-06-04
EBIT	$523M
EBITDA	$801.4M
EPS	$1.46
F Score	6
FCF	$358M
FCF EV Yield	3.4x
Financing CF	-347,835,852
Fiscal Year End	October
Founded	1,958
Goodwill	2,864,665,575.6
Graham Number	44.08097
Graham Upside	-26.26
Income Tax	$148.7M
Investing CF	-276,256,890
Is Primary Listing	0
Last Earnings Date	2026-03-05
Last Report Date	2026-01-31
Last Split Date	2024-02-20
Last Split Type	Forward
Lynch Fair Value	$10.18
Lynch Upside	-82.97
Ma150	75.08
Ma150ch	-20.38%
Ma20	65.31
Ma20ch	-8.47%
Net CF	17,493,840
Next Earnings Date	2026-06-04
Open	61.17
P FCF Ratio	24
P OCF Ratio	13.6
Position In Range	0
Ppne	1,552,629,083.8
Price Date	2026-05-08
Price EBITDA	$10.72
Ptbv Ratio	4.04
Relative Volume	1.55x
Revenue	3,026,288,538x
SBC By Revenue	1.7x
Share Based Comp	51,388,155
Tax By Revenue	4.91x
Tax Rate	33.7%
Tr6m	-13.79%
Volume	1,086
Z Score	3.71

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does LON/0I3I pay a dividend?

Capital-return profile for this ticker.

Performance

LON/0I3I stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns LON/0I3I?

Insider, institutional, and short-interest positioning.

Institutional ownership

+106.1%

Share of float held by funds and institutions

Insider ownership

+0.6%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

LON/0I3I momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

25.4

Below 30: short-term oversold

Price vs 200-day MA

-19.0%

50/200-day relationship not available

Beta (5Y)

0.89

Moves roughly with the market

Sharpe ratio

-0.81

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About LON/0I3I

Hub-level FAQ points readers to the deeper analysis pages.

What is the current lon/0I3I stock rating?

lon/0I3I is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full lon/0I3I analysis?

The full report lives at /stocks/lon/0I3I/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for lon/0I3I?

The latest report frames lon/0I3I around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the lon/0I3I page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.